1 unchanged sentence
Trading Arrangements
−Removed: From time to time, our officers (as defined in Rule 16a - 1 (f) of the Exchange Act) and directors may enter into Rule 10b5 - 1 or non-Rule 10b5 - 1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K).
−Removed: During the three months ended September 30, 2025 , none of our officers or directors adopted or terminated any such trading arrangements except as set forth below:
−Removed: Name Action Taken Type of Nature of Duration of Aggregate Number
−Removed: ( Title ) ( Date of Action ) Trading Arrangement Trading Arrangement Trading Arrangement of Securities
−Removed: Carmine Stengone
−Removed: ( President and Chief Executive Officer )
−Removed: ( September 23, 2025 )
−Removed: Rule 10b5 - 1 trading arrangement* Sale Until November 30, 2026 , or such earlier date upon which all transactions are completed or expire without execution Up to 231,925 shares
−Removed: ( Chief Financial Officer )
−Removed: ( September 23, 2025 )
−Removed: Rule 10b5 - 1 trading arrangement* Sale Until November 18, 2026 , or such earlier date upon which all transactions are completed or expire without execution Up to 41,730 shares
−Removed: Daniel Lorrain , Ph.D.
−Removed: ( Chief Scientific Officer )
−Removed: ( September 23, 2025 )
−Removed: Rule 10b5 - 1 trading arrangement* Sale Until November 30, 2026 , or such earlier date upon which all transactions are completed or expire without execution Up to 221,245 shares
−Removed: Timothy Watkins , M.D., M.Sc.
−Removed: ( Chief Medical Officer and Head of Development )
−Removed: ( September 23, 2025 )
−Removed: Rule 10b5 - 1 trading arrangement* Sale Until December 27, 2026 , or such earlier date upon which all transactions are completed or expire without execution Up to 173,333 shares
−Removed: * Intended to satisfy the affirmative defense of Rule 10b5 - 1 (c)
−Removed: Incorporated by Reference
+Added: During the quarter ended March 31, 2026, none of our directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K).
+Added: Exhibit Incorporated by Reference Filed
+Added: Number Description Form File No.
+Added: Exhibit Filing Date Herewith
3.1 Amended and Restated Certificate of Incorporation of the Registrant.
+Added: 8-K 001-42001 3.1 04/09/2024
3.2 Amended and Restated Bylaws of the Registrant.
+Added: 8-K 001-42001 3.2 04/09/2024
+Added: 10.1 2026 Employment Inducement Equity Incentive Plan and forms of agreements thereunder .
+Added: 10.16 03/05/2026
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
−Removed: Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
+Added: 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
3 unchanged sentences
Contineum Therapeutics, Inc.
−Removed: October 30, 2025
/s/ Carmine Stengone
2 unchanged sentences
(Principal Executive Officer)
−Removed: October 30, 2025
/s/ Peter Slover
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.